TARA — Protara Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Protara Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	91.2	84.4	65.6	170	156
Net Total Accounts Receivable
Net Total Receivables	—	0.486	0.242	0	1.26
Prepaid Expenses
Total Other Current Assets
Total Current Assets	93.1	86.1	68.7	172	160
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.89	7.87	6.56	5.28	3.93
Net Goodwill
Long Term Investments
Other Long Term Assets
Total Assets	173	113	79	181	209
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	4.3	5.74	6.15	11	10.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.7	11.2	10.6	14.3	13.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	162	102	68.3	167	196
Total Liabilities & Shareholders' Equity	173	113	79	181	209
Total Common Shares Outstanding
Total Preferred Shares Outstanding